Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

First DXM Age Law Passes While Voluntary Restrictions Increase

This article was originally published in The Tan Sheet

Executive Summary

A New York county adopts an ordinance limiting sales of dextromethorphan products to consumers 19 years old and up, while trade groups are looking to a uniform national solution that will curb abuse, maintain consumer access and limit retailer burdens

You may also be interested in...



N.J. Lawmakers To Consider Age Restriction For DXM

The state legislature’s Law and Public Safety Committee in November unanimously passed the bill to require photo identification for purchases of products containing dextromethorphan and impose a fine of up to $750 on employees and retail establishments for violations.

N.J. Lawmakers To Consider Age Restriction For DXM

The state legislature’s Law and Public Safety Committee in November unanimously passed the bill to require photo identification for purchases of products containing dextromethorphan and impose a fine of up to $750 on employees and retail establishments for violations.

Students’ OTC Cough/Cold Drug Abuse Steady, Monitoring Survey Says

Results of the latest national survey of students' illicit drug use show no change in the prevalence of young people abusing OTC cough and cold medicines, and the head researcher says "there is little evidence yet of much improvement" in preventing misuse

Related Content

Topics

UsernamePublicRestriction

Register

PS100521

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel